Skip to content

The effect of sour tea (Hibiscus sabdariffa L.) on the lipid

The effect of sour tea consumption (Hibiscus sabdariffa L.) on the lipid profile in dyslipidemic subjects

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201008224612N1
Enrollment
80
Registered
2012-04-30
Start date
2011-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polygenic Dyslipidemia. Mixed hyperlipidaemia

Interventions

Treatment - Other
Lifestyle
Intervention 1: Intervention group: The Intervention group will receive lifestyle modification education at baseline and then consume two cups of sour tea extract daily between morning and evening mea
Intervention group: The Intervention group will receive lifestyle modification education at baseline and then consume two cups of sour tea extract daily between morning and evening meals for 90 days (
Control group: The Control group will receive lifestyle modification education at baseline only and do not consume sour tea.

Sponsors

the International Branch of Shahid Beheshti University of Medical Sciences & Health Services
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Polygenic dyslipidemia as defined; not intaking lipid lowering drugs Exclusion criteria: allergy to tea; not interested in consuming tea; take a trip; having other diseases such as familial dyslipidemia; diabetes; cardiovascular disease; kidney and liver diseases

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Total cholesterol. Timepoint: Baseline, six weeks and twelve weeks after intervention. Method of measurement: Cholesterol oxidase enzymatic method.

Secondary

MeasureTime frame
LDL-C. Timepoint: Baseline, six weeks and twelve weeks after intervention. Method of measurement: Fridvald is calculated using the formula.;HDL-c. Timepoint: Baseline, six weeks and twelve weeks after intervention. Method of measurement: Cholesterol oxidase enzymatic method.;Triglyceride. Timepoint: Baseline, six weeks and twelve weeks after intervention. Method of measurement: Glycerol oxidase enzymatic methods.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarihe Ahmadzadeh Sani

the International Branch of Shahid Beheshti University of Medical Sciences & Health Services

farihe_ahmadzadeh1384@gmu.ac.ir+98 53 3722 1929

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026